qo_q3_2019_1024x768_kvp

China will be the first to sail out of the Global Storm…

Quarterly Outlook

Summary:  The paradox here is that from Q2 China's growth is likely to accelerate as the rest of the world decelerates.


As we go to press, the only thing that I have complete conviction on is a lack of conviction in the near term. 

We are in the midst of the epitome of a bear market in equities. A lot of the price moves we are seeing across asset classes are clear signs of distress and the fight for liquidity over anything fundamental or rational. Fear, plus the fear of fear, reign supreme. That the VIX is over 80 — some seven times higher than mid-January, with a 12 handle – is a testament to that. 

There is blood on the street and positions are being slaughtered: the S&P is down 25% year to date. However, one has to take a step back and remember that this is what happens after you have the longest bull market run in history. The S&P climbed around 400% from its 2009 lows to its all-time high of around 3390. Other names such as Amazon are still up over 1200%, despite a 20% pullback from its recent all-time high.

As always, context is everything. This too shall pass, life will continue and eventually uncertainty — and fear — will peter away. After more education and curbing measures, time decay on virus concerns will set in. As the rest of the world catches up with what Asia went through in January and February, fears will generally lessen. 

We need a resetting of expectations around fundamentals and earnings as policymakers deal with the challenge of the triple threats: a demand shock, a supply shock and the destruction of capital in the energy market (where once again Putin demonstrated that he is the undisputed Grandmaster of all chess moves). 

The point to keep in mind is not about the validity of the rising numbers of virus cases in the US and Europe. Instead it is direction and the fact that Asia (especially China, Hong Kong and Singapore) has a lot of historical experience, expertise, resources and procedures for dealing with outbreaks – especially given the epicentres of SARS ten years ago. Europe and the US just don’t have that. What we will see in the next few weeks is the exceptional job China, Singapore & Hong Kong have done of containment. The numbers in Europe and the US are likely to get dramatically higher over the next four to eight weeks. 

However, with the Northern Hemisphere summer coming in, time is on their side. That, plus a potential breakthrough toward a vaccine. These are potential advantages that Asia did not initially have.  

While China has lead the world in regards to the economic slowdown that we are in the midst of – talks suggest Q1 China GDP could be in the -10% to -20% range – we are also likely going to be entering a quarter or two where that slowdown ripples across the eurozone and the US.

So the paradox here is that from Q2 China’s growth is likely to accelerate as the rest of the world decelerates. For those who will rightly flag that the US and eurozone will have lower demand for Chinese goods, don’t forget Asia’s demographics and secular consumer spending, healthcare, biotech and infrastructure themes. China does about 50% of its trade with Asia.

Most of Asia benefits more from rising growth in China than rising growth in the US or eurozone. Also bear in mind that China will be coming from the lowest of bases: zero. Construction companies, real estate and infrastructure-linked players should be the first place for investors to look. With an eventual return to the service economy – restaurant chains are once again opening across the country – some provinces are claiming to be almost back to 100% normal. 

The higher beta names that face China are obviously Singapore, South Korea and Taiwan. They are still not yet showing signs of economic traction upward, but are worth monitoring closely for a follow through of Chinese activity later this quarter. 

Blue-chip, high-dividend and solid balance sheet names are worth looking into. In a world with ever structurally lower yields (the Fed has now cut rates by 150 basis points in March alone), names like CK Hutchison (1 HK) are yielding close to 6% unlevered. Alternatively, Altria (MO, old Philip Morris) are yielding around 9% unlevered — and that’s with respective -30% & -23% YTD pullbacks respectively. 

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.